Randomized phase II trial on primary chemotherapy with high-dose methotrexate (HD-MTX) alone or associated with high-dose cytarabine (HD-araC) for patients with primary CNS lymphoma (IELSG #20 Trial): Tolerability, activity, and survival analyses

Autor: Ferreri AJ, Reni M, Martelli M, Pangalis G, Frezzato M, Cabras G, Fabbri A, Corazzelli G, Zucca E, Cavalli F
Přispěvatelé: Ferreri, Aj, Reni, M, Martelli, M, Pangalis, G, Frezzato, M, Cabras, G, Fabbri, A, Corazzelli, G, Zucca, E, Cavalli, F
Jazyk: angličtina
Rok vydání: 2009
Databáze: OpenAIRE